drugset / Trial / NCT02277574
Assess Safety, Tolerability, Pharmacokinetics and Clinical Activity of AMP-110 in Subjects With Rheumatoid Arthritis
RandomizedCrossoverTriple-blindTreatment
Summary
This is a Phase 1b, randomized, multi-dose, placebo-controlled, dose-escalation, multi-center study of AMP-110 in adult subjects with rheumatoid arthritis.
Timeline
- Start
- 2014-06
- Primary completion
- 2015-01
- Completion
- 2015-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | AMP-110 | Unknown | 2 mg/kg | — |
| Subject | AMP-110 | Unknown | 5 mg/kg | — |
| Subject | AMP-110 | Unknown | 10 mg/kg | — |